Prolonged efficacy of sotatercept in pulmonary arterial hypertension demonstrated

被引：0
|
作者：
Lichert, Frank
机构：
来源：
PNEUMOLOGIE | 2023年 / 77卷 / 07期
关键词：
D O I：
10.1055/a-2039-7782
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：402 / 402
页数：1
相关论文
共 50 条
  • [41] Results of a Planned Analysis of the Effects of Genetic Background on Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Montani, D.
    Mclaughlin, V. V.
    Gibbs, J. S. R.
    Gomberg-Maitland, M.
    Hoeper, M. M.
    Preston, I. R.
    Souza, R.
    Waxman, A. B.
    Subias, P. Escribano
    Feldman, J. P.
    Meyer, G. Bohns
    Olsson, K. M.
    Manimaran, S.
    Zhao, Y.
    Lau, A.
    Pena, J.
    Badesch, D. B.
    Humbert, M. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [42] Sotatercept for the Treatment of Pulmonary Arterial Hypertension: A Systematic Review and Single-Arm Meta-Analysis
    Felix, Nicole
    Teixeira, Larissa
    Campedelli, Luiz
    Nogueira, Alleh
    Godoi, Amanda
    Marinho, Alice Deberaldini
    Marinho, Beatriz Deberaldini
    Perim, C. N. Victor
    Costa, Thomaz A.
    Risbano, Michael G.
    CIRCULATION, 2023, 148
  • [43] Prognostic Value of the Multicomponent Improvement (MCI) Endpoint in Patients With Pulmonary Arterial Hypertension (PAH) Treated With Sotatercept
    Waxman, A. B.
    Badesch, D. B.
    Gibbs, J. S. R.
    Ghofrani, H. A.
    Gomberg-Maitland, M.
    Humbert, M. J.
    Mclaughlin, V. V.
    Preston, I. R.
    Souza, R.
    Grunig, E.
    Kope, G.
    Meyer, G. Bohns
    Olsson, K. M.
    Rosenkranz, S.
    Zhao, Y.
    Lau, A.
    Cornell, A. G.
    Pena, J.
    Hoeper, M. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [44] Sotatercept: The First FDA-Approved Activin A Receptor IIA Inhibitor Used in the Management of Pulmonary Arterial Hypertension
    Villanueva, Josiah
    Wade, Jasmine
    Torres, Ana
    Hale, Genevieve
    Pham, Huy
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (01) : 17 - 24
  • [45] Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Nashat, Heba
    Da Costa, Rosa
    Barbosa, Joanna
    Harries, Carl
    Kempny, Aleksander
    Price, Laura C.
    Mc Cabe, Colm
    Gatzoulis, Michael A.
    Dimopoulos, Konstantinos
    Wort, Stephen J.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [46] Is sotatercept, which traps activins and growth differentiation factors, a new dawn in treating pulmonary arterial hypertension (PAH)?
    Doggrell, Sheila A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (07) : 589 - 593
  • [47] Safety and Efficacy of Ambrisentan in the Treatment of Pulmonary Arterial Hypertension
    Valerio, Christopher J.
    Kabunga, Peter
    Coghlan, John G.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 541 - 556
  • [48] EFFICACY OF CAPTOPRIL (TENSIOMINE) DURING PROLONGED ARTERIAL-HYPERTENSION TREATMENT
    KAKALIYA, E
    BELOUSOV, YB
    BYKOV, AV
    SIDORSKY, AL
    SOVETSKAYA MEDITSINA, 1991, (10): : 45 - 48
  • [49] Population Pharmacokinetic/Pharmacodynamic and Exposure-Response Modeling Analyses of Sotatercept in Healthy Participants and Patients with Pulmonary Arterial Hypertension
    Ait-Oudhia, Sihem
    Jaworowicz, David
    Hu, Ziheng
    Gaurav, Mitali
    Barcomb, Heather
    Hu, Shuai
    Bihorel, Sebastien
    Balasubrahmanyam, Budda
    Mistry, Bipin
    de Oliveira Pena, Janethe
    Wenning, Larissa
    Gheyas, Ferdous
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (03) : 798 - 807
  • [50] Activin Receptor Type IIA-Fc (Sotatercept) Suppresses Inflammation to Alleviate Pulmonary Arterial Hypertension in Preclinical Models
    Joshi, S. R.
    Liu, J.
    Pearsall, R.
    Andre, P.
    Li, G.
    Kumar, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345